| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 84241 |
Mc-vc-PABC-SP 141,一种用于抗体药物偶联物(ADC)合成的linker或连接臂 |
226 |
WYQ |
2024-12-19 |
| 84242 |
perfluorophenyl 1-(1,3-dioxoisoindolin-2-yloxy)-3,6,9,12-tetraoxapentadecan-15-oate |
232 |
wyh |
2024-12-19 |
| 84243 |
cas:2055041-37-5,Mal-PEG1-Val-Cit-PAB-OH,马来酰亚胺-一聚乙二醇-VAL-CIT-PAB-羟基 |
226 |
kx |
2024-12-19 |
| 84244 |
perfluorophenyl 15-(2,5-dioxo-2H-pyrrol-1(5H)-yl)-13-oxo-3,6,9-trioxa-12-azapentadecan-1-oate |
156 |
wyh |
2024-12-19 |
| 84245 |
MC-Val-Cit-PAB-PNP cas:159857-81-5 |
219 |
zyl |
2024-12-19 |
| 84246 |
NAMPT-linker(CAS号:2241019-57-6) |
161 |
WYQ |
2024-12-19 |
| 84247 |
cas:103848-61-9,6-Maleimidocaproic acid sulfo-NHS |
176 |
wyh |
2024-12-19 |
| 84248 |
cas:159857-80-4 ,MC-Val-Cit-PAB-OH, ADC(抗体偶联药物 ) |
157 |
kx |
2024-12-19 |
| 84249 |
Boc-Val-Cit cas:870487-08-4 |
206 |
zyl |
2024-12-19 |
| 84250 |
cas:663598-66-1,1-((4-((5-Nitropyridin-2-yl)disulfanyl)pentanoyl)oxy)-2,5-dioxopyrrolidine-3-sulfonic acid |
169 |
wyh |
2024-12-19 |
| 84251 |
cas:870487-10-8,Boc-Val-Cit-PAB-PNP,BOC-VAL-CIT-PAB-PNP 酯 |
153 |
kx |
2024-12-19 |
| 84252 |
cas:2353409-69-3 Mal-PEG8-Val-Cit-PAB-MMAE |
209 |
zyl |
2024-12-19 |
| 84253 |
cas:108852-90-0 Nemorubicin 奈莫柔比星 |
180 |
zyl |
2024-12-19 |
| 84254 |
cas:159858-22-7 , Fmoc-Val-Cit-PAB-OH,ADC(抗体偶联药物) |
157 |
kx |
2024-12-19 |
| 84255 |
cas:1626359-59-8 磺基-SPDB-DM4 |
131 |
zyl |
2024-12-19 |
| 84256 |
cas:870487-09-5,Boc-Val-Cit-PAB, ADC试剂 |
130 |
kx |
2024-12-19 |
| 84257 |
NH2-Glu-Gly-Cit-PAB-OH, ADC试剂 |
210 |
kx |
2024-12-19 |
| 84258 |
sulfo-SPDB-DGN462,用于提高化合物的水溶性和稳定性 |
254 |
WYQ |
2024-12-19 |
| 84259 |
Fmoc-Gly-Gly-Phe-Gly-OH, ADC试剂 |
192 |
kx |
2024-12-19 |
| 84260 |
1342211-31-7,MC-Val-Ala-OH,马来酰亚胺基己酰-L-缬氨酰-L-丙氨酸,ADC连接子多肽 |
218 |
kx |
2024-12-19 |
| 84261 |
MA-PEG4-VC-PAB-DMAE-PNU159682(CAS号:2259318-52-8) |
161 |
WYQ |
2024-12-19 |
| 84262 |
MC-vc-PAB-C6-a-amanitin,一种抗体药物偶联物(ADC) |
188 |
WYQ |
2024-12-19 |
| 84263 |
cas:690632-55-4,N-Succinimidyloxycarbonylpropyl Methanethiosulfonate |
115 |
wyh |
2024-12-19 |
| 84264 |
VC-MMAF(CAS号:863971-17-9) |
164 |
WYQ |
2024-12-19 |
| 84265 |
cas:159857-70-2 MC-Val-Cit-Doxorubicin-ADC抗体偶联药物 |
130 |
zyl |
2024-12-19 |
| 84266 |
2055024-62-7,NH2-PEG3-Val-Cit-PAB-OH, ADC试剂 |
146 |
kx |
2024-12-19 |
| 84267 |
cas:1834516-06-1 Fmoc-Ala-Ala-Asn-PABC-PNP |
152 |
zyl |
2024-12-19 |
| 84268 |
perfluorophenyl 1-(1,3-dioxoisoindolin-2-yloxy)-3,6,9,12-tetraoxapentadecan-15-oate |
178 |
wyh |
2024-12-19 |
| 84269 |
MC -Val-Cit, ADC试剂 |
221 |
kx |
2024-12-19 |
| 84270 |
cas:141534-26-1,2-(4-formylbenzamido)ethyl nitrate |
212 |
wyh |
2024-12-19 |
| 84271 |
cas:159857-81-5 Mc-Val-Cit-PABC-PNP |
157 |
zyl |
2024-12-19 |
| 84272 |
MC-PEG4-va-PAB-Exatecan, ADC试剂 |
322 |
kx |
2024-12-19 |
| 84273 |
cas:2101206-44-2 PY-DS-DMBUT-OPFP |
185 |
zyl |
2024-12-19 |
| 84274 |
Perfluorophenyl 3-(2-(2-(4-formylbenzamido)ethoxy)ethoxy)propanoate |
134 |
wyh |
2024-12-19 |
| 84275 |
SMCC-DM4(CAS号:1228105-52-9) |
151 |
WYQ |
2024-12-19 |
| 84276 |
NHS ester-PEG4-VC-PAB-Dxd, ADC试剂 |
348 |
kx |
2024-12-19 |
| 84277 |
cas:53053-08-0,4-azidobenzoic acid N-hydroxysuccinimide ester |
129 |
wyh |
2024-12-19 |
| 84278 |
N3-Linker-Gefitinib,Gefitinib本身具有*肿瘤活性 |
206 |
WYQ |
2024-12-19 |
| 84279 |
Boc-Val-Cit-OH的介绍 |
164 |
zyl |
2024-12-19 |
| 84280 |
mDPR-Val-Ala-PAB-MMAE, ADC试剂 |
222 |
kx |
2024-12-19 |
| 84281 |
Boc-Val-Ala-PAB-OC2H5 | ADC Linker |
187 |
zyl |
2024-12-19 |
| 84282 |
cas:2259318-56-2,DBCO-PEG4-VC-PAB-DMAE-PNU159682, ADC试剂 |
173 |
kx |
2024-12-19 |
| 84283 |
Mc-Dexamethasone,CAS号:1618096-56-2 |
180 |
WYQ |
2024-12-19 |
| 84284 |
N3-PEG4-YPYDVPDYA-Doxorubicin,抗体偶联药物(ADC)的一部分 |
198 |
WYQ |
2024-12-19 |
| 84285 |
DBCO-PEG4-VA-PAB-EDA-N-Ac-Calicheamicin,ADC定制 |
237 |
kx |
2024-12-19 |